Inc. MYGN. Notably, PetMed, Align Technology and Myriad Genetics sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank …
Despite a long history of profitability, solid free cash flow, no debt, a forward P/E of 20, and ties to the once-raging hot and now cooling off healthcare and biotech spaces, MYGN stock somehow hasn’t caught the attention of more aggressive …
What does the smart money think about Myriad Genetics, Inc. (NASDAQ:MYGN)? Heading into 2013, a total of 21 of the hedge funds we track held long positions in this stock, a change of 5% from one quarter earlier. With hedge funds’ …
Myriad Genetics, Inc. MYGN was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for …
MYGN), and today is no different. The biotech stock is up 4.7% to trade at $19.51, ahead of tomorrow's start to the American Society of Human Genetics Annual Meeting in Vancouver -- where MYGN is expected to present data from …
Shares of genetic-testing leader Myriad Genetics (NASDAQ:MYGN) dropped over 18% today ... It was a double-blind, randomized study -- the most robust design. So why did the stock drop? At the very bottom of the press release, …
A new research note from Cantor Fitzgerald profiles stocks with upcoming earnings ... The company reports earnings on November 6. Myriad Genetics Inc. (NASDAQ: MYGN) is a biotech stock that has hammered the shorts so far this year, …
Myriad Genetics, Inc. (Nasdaq: MYGN) announced that its Board of Directors has approved a two-for-one split of the Company's common stock, effected in the form of a stock dividend. The stock dividend is payable on March 25, 2009 to …
Myriad Genetics Inc. (MYGN) reported fourth quarter EPS of $0.30 after the bell ... Shares finished up by 2.43 at $27.98 on above average volume. The stock broke out of a month and a half long trading range and set nearly a 52-week high.
The stock PBYI, -0.16% soared $170.83 ... The Russell 3000 biotech stocks with the highest short-interest percentages are Myriad Genetics MYGN, -0.93% at 51%, Exact Sciences EXAS, -0.44% at 32% and MannKind MNKD, +2.65% at …